Clinical trial

Role of Pentoxifylline and Celecoxib in Parkinsonism

NCT05962957

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-08-07

PhasePHASE2

Study timeline

Study start (actual)2023-08-07Date precision: day

Registry last updated2025-08-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Diseaseunresolved

Interventions

carbidopa-levodopaDRUG

Pentoxifylline 400 MGDRUG · verified · RxNorm: pentoxifylline 400 MG

Celecoxib 200mgDRUG

Sponsors & collaborators

Mostafa Bahaalead sponsor

Tanta Universitycollaborator

Mohanad Omar Khrieba Clinical Pharmacy Department, Faculty of Pharmacy - Horus Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05962957 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.